GENENTECH, INC. — TTAB Proceedings
GENENTECH, INC. is a party to 50 TTAB proceedings.
Proceedings
- Proceeding 99267970 — Extensions of Time to Oppose, Not Instituted (filed 2026-01-20) against Maeil Health Nutrition Co., Ltd. as plaintiff
- Proceeding 91302832 — Oppositions, Terminated (filed 2025-11-03) against Bausch Health Ireland Limited as defendant
- Proceeding 99015309 — Extensions of Time to Oppose, Terminated (filed 2025-09-10) against Gentech USA LLC as plaintiff
- Proceeding 98894970 — Extensions of Time to Oppose, Terminated (filed 2025-06-05) against Bausch Health Ireland Limited as defendant
- Proceeding 98535422 — Extensions of Time to Oppose, Terminated (filed 2024-12-13) against Biocon Biologics Limited as plaintiff
- Proceeding 79367968 — Extensions of Time to Oppose, Terminated (filed 2023-07-19) against NOVARTIS AG as plaintiff
- Proceeding 90799528 — Extensions of Time to Oppose, Terminated (filed 2023-05-02) against MaxScientific Inc. as plaintiff
- Proceeding 97431092 — Extensions of Time to Oppose, Terminated (filed 2023-08-17) against Empire Pharmaceutical Inc. as plaintiff
- Proceeding 91272599 — Oppositions, Terminated (filed 2021-10-28) against Design Therapeutics, Inc. as plaintiff
- Proceeding 90523874 — Extensions of Time to Oppose, Terminated (filed 2022-10-12) against Compass Pathfinder Limited as defendant
- Proceeding 97083862 — Extensions of Time to Oppose, Terminated (filed 2022-09-28) against PlayMakar Inc. as plaintiff
- Proceeding 90614502 — Extensions of Time to Oppose, Terminated (filed 2022-05-04) against JOHNSON & JOHNSON as plaintiff
- Proceeding 90263391 — Extensions of Time to Oppose, Terminated (filed 2021-05-20) against Design Therapeutics, Inc. as plaintiff
- Proceeding 90382969 — Extensions of Time to Oppose, Terminated (filed 2021-05-05) against Merck Sharp & Dohme Corp. as plaintiff
- Proceeding 91266546 — Oppositions, Terminated (filed 2020-12-16) against H. Lundbeck A/S as defendant
- Proceeding 91266548 — Oppositions, Terminated (filed 2020-12-16) against LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC. as defendant
- Proceeding 88882540 — Extensions of Time to Oppose, Terminated (filed 2020-09-14) against LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC. as defendant
- Proceeding 88882555 — Extensions of Time to Oppose, Terminated (filed 2020-09-14) against H. Lundbeck A/S as defendant
- Proceeding 88232272 — Extensions of Time to Oppose, Terminated (filed 2019-05-16) against Gilead Sciences Ireland UC as defendant
- Proceeding 87146201 — Extensions of Time to Oppose, Terminated (filed 2016-12-08) against JAZZ PHARMACEUTICALS, INC. as defendant
- Proceeding 91219664 — Oppositions, Terminated (filed 2014-12-08) against L&Z US Inc. as plaintiff
- Proceeding 86289558 — Extensions of Time to Oppose, Terminated (filed 2014-10-28) against L&Z US Inc. as plaintiff
- Proceeding 91214731 — Oppositions, Terminated (filed 2014-01-30) against Actavis, Inc. as plaintiff
- Proceeding 91214732 — Oppositions, Terminated (filed 2014-01-30) against Actavis, Inc. as plaintiff
- Proceeding 91214560 — Oppositions, Terminated (filed 2014-01-21) against Actavis, Inc. as plaintiff
- Proceeding 91216071 — Oppositions, Terminated (filed 2014-04-24) against Actavis, Inc. as plaintiff
- Proceeding 91217661 — Oppositions, Terminated (filed 2014-07-31) against Actavis, Inc. as plaintiff
- Proceeding 86097851 — Extensions of Time to Oppose, Terminated (filed 2014-07-14) against ACTAVIS, INC. as plaintiff
- Proceeding 91218183 — Oppositions, Terminated (filed 2014-09-02) against Actavis Group PTC ehf as plaintiff
- Proceeding 91215538 — Oppositions, Terminated (filed 2014-03-20) against Actavis Group PTC ehf. as plaintiff
- Proceeding 86097858 — Extensions of Time to Oppose, Terminated (filed 2014-09-02) against ACTAVIS, INC. as plaintiff
- Proceeding 91215252 — Oppositions, Terminated (filed 2014-03-04) against Actavis Group PTC ehf as plaintiff
- Proceeding 86097841 — Extensions of Time to Oppose, Terminated (filed 2014-06-06) against ACTAVIS, INC. as plaintiff
- Proceeding 85868201 — Extensions of Time to Oppose, Terminated (filed 2014-06-24) against ACTAVIS, INC. as plaintiff
- Proceeding 79130027 — Extensions of Time to Oppose, Terminated (filed 2014-03-24) against Actavis Group PTC ehf as plaintiff
- Proceeding 85830300 — Extensions of Time to Oppose, Terminated (filed 2014-02-27) against ACTAVIS, INC. as plaintiff
- Proceeding 86146489 — Extensions of Time to Oppose, Terminated (filed 2014-03-20) against Novartis AG as defendant
- Proceeding 85951480 — Extensions of Time to Oppose, Terminated (filed 2013-11-25) against Actavis, Inc. as plaintiff
- Proceeding 85848114 — Extensions of Time to Oppose, Terminated (filed 2013-10-03) against Actavis, Inc. as plaintiff
- Proceeding 79109296 — Extensions of Time to Oppose, Terminated (filed 2013-10-03) against Actavis Group PTC ehf. as plaintiff
- Proceeding 79128751 — Extensions of Time to Oppose, Terminated (filed 2013-10-03) against Actavis Group PTC ehf as plaintiff
- Proceeding 85773894 — Extensions of Time to Oppose, Terminated (filed 2013-08-16) against ACTAVIS, INC. as plaintiff
- Proceeding 85773902 — Extensions of Time to Oppose, Terminated (filed 2013-08-16) against ACTAVIS, INC. as plaintiff
- Proceeding 85839782 — Extensions of Time to Oppose, Terminated (filed 2013-08-16) against Actavis, Inc. as plaintiff
- Proceeding 85489650 — Extensions of Time to Oppose, Terminated (filed 2013-05-17) against MERZ PHARMA GmbH & CO. KGaA as plaintiff
- Proceeding 85755540 — Extensions of Time to Oppose, Terminated (filed 2013-04-19) against Millennium Pharmaceuticals, Inc. as plaintiff
- Proceeding 91205038 — Oppositions, Terminated (filed 2012-05-04) against Lupin Ltd. as plaintiff
- Proceeding 85352341 — Extensions of Time to Oppose, Terminated (filed 2011-12-02) against Lupin Ltd. as plaintiff
- Proceeding 85367666 — Extensions of Time to Oppose, Terminated (filed 2011-12-16) against Hospira, Inc. as plaintiff
- Proceeding 85341045 — Extensions of Time to Oppose, Terminated (filed 2011-11-18) against Bayer Aktiengesellschaft as plaintiff
Marks in These TTAB Matters
- VYVHALI — proceeding 91302832 (Defendant)
- VYVHALI — proceeding 98894970 (Defendant)
- COMPASS — proceeding 90523874 (Defendant)
- GENENTECH BIOONCOLOGY — proceeding 91272599 (Plaintiff)
- GENENTECH'S THROMBOLYTIC EXPERIENCE — proceeding 91272599 (Plaintiff)
- GENENTECH — proceeding 91272599 (Plaintiff)
- ZEPTIVTY — proceeding 91266548 (Defendant)
- KYDUITY — proceeding 91266546 (Defendant)
- KYDUITY — proceeding 88882555 (Defendant)
- ZEPTIVTY — proceeding 88882540 (Defendant)
- HERCEPTIN HYLECTA — proceeding 88232272 (Defendant)
- XIBIXI — proceeding 87146201 (Defendant)
- CATHFLO — proceeding 91219664 (Plaintiff)
- CATHFLO ACTIVASE (ALTEPLASE) THE ONE 2-MG T-PA — proceeding 91219664 (Plaintiff)
- CATHFLO ACTIVASE (ALTEPLASE) THE ONE 2-MG T-PA — proceeding 91218183 (Plaintiff)
- ACTIVASE — proceeding 91218183 (Plaintiff)
- ACTIVASE ALTEPLASE A RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR THE ONE T-PA FOR STROKE — proceeding 91218183 (Plaintiff)
- ACTIVASE ALTEPLASE A RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR THE ONE T-PA FOR STROKE — proceeding 91217661 (Plaintiff)
- ACTIVASE — proceeding 91217661 (Plaintiff)
- CATHFLO ACTIVASE (ALTEPLASE) THE ONE 2-MG T-PA — proceeding 91217661 (Plaintiff)
- ACTIVASE ALTEPLASE A RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR THE ONE T-PA FOR STROKE — proceeding 91216071 (Plaintiff)
- CATHFLO ACTIVASE (ALTEPLASE) THE ONE 2-MG T-PA — proceeding 91216071 (Plaintiff)
- ACTIVASE — proceeding 91216071 (Plaintiff)
- COBI — proceeding 86146489 (Defendant)
- ACTIVASE — proceeding 91215538 (Plaintiff)
Recent Live Filings
- OMLIAGO — Pending, filed 2026-04-21
- ENVYNZYBA — Pending, filed 2026-04-21
- HUNTISO — Pending, filed 2026-04-20
- HUNTIFOR — Pending, filed 2026-04-20
- MARHUNTO — Pending, filed 2026-04-20
- TS-MICRO — Pending, filed 2026-02-24
- ENZIGZI — Pending, filed 2026-02-11
- AXFIBZI — Pending, filed 2026-02-11
- QZEVTA — Pending, filed 2026-02-11
- KUDOCETRO — Pending, filed 2026-02-03
- OMFABIZ — Pending, filed 2026-01-26
- FEXBEPVI — Pending, filed 2026-01-26
- IQAYLA — Pending, filed 2026-01-26
- PORTAVIT — Pending, filed 2026-01-22
- ERABALYZ — Pending, filed 2026-01-20
Common TTAB Counterparties
- ACTAVIS, INC. — 15 proceedings
- Actavis Group PTC ehf. — 6 proceedings
- Altus Pharmaceuticals Inc. — 4 proceedings
- GLAXO GROUP LIMITED — 4 proceedings
- NOVARTIS AG — 4 proceedings
- CHUGAI-UPJOHN, INC. — 3 proceedings
- Active Organics, Inc. — 2 proceedings
- ASTRA ZENECA AB — 2 proceedings
- Bausch Health Ireland Limited — 2 proceedings
- Daiichi Sankyo, Inc. — 2 proceedings
Recent TTAB Timeline
- 2026-04-22: 99267970 — EXTENSION OF TIME GRANTED involving Maeil Health Nutrition Co., Ltd.
- 2026-04-22: 99267970 — FINAL 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Maeil Health Nutrition Co., Ltd.
- 2026-02-21: 99267970 — EXTENSION OF TIME GRANTED involving Maeil Health Nutrition Co., Ltd.
- 2026-02-21: 99267970 — ADD'L 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Maeil Health Nutrition Co., Ltd.
- 2026-01-20: 99267970 — EXTENSION OF TIME GRANTED involving Maeil Health Nutrition Co., Ltd.
- 2026-01-20: 99267970 — FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE involving Maeil Health Nutrition Co., Ltd.
- 2026-01-06: 91302832 — TERMINATED involving Bausch Health Ireland Limited
- 2026-01-06: 91302832 — BD'S DECISION: DISMISSED W/O PREJUDICE involving Bausch Health Ireland Limited
- 2025-12-31: 91302832 — WITHDRAWAL OF APPLICATION involving Bausch Health Ireland Limited
- 2025-12-31: 91302832 — D CHANGE OF CORRESP ADDRESS involving Bausch Health Ireland Limited
- 2025-12-08: 99015309 — P CHANGE OF CORRESP ADDRESS involving Gentech USA LLC
- 2025-11-03: 91302832 — PENDING, INSTITUTED involving Bausch Health Ireland Limited
- 2025-11-03: 91302832 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Bausch Health Ireland Limited
- 2025-11-03: 91302832 — FILED AND FEE involving Bausch Health Ireland Limited
- 2025-10-07: 99015309 — EXTENSION OF TIME GRANTED involving Gentech USA LLC
- 2025-10-07: 99015309 — ADD'L 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Gentech USA LLC
- 2025-09-10: 99015309 — EXTENSION OF TIME GRANTED involving Gentech USA LLC
- 2025-09-10: 99015309 — FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE involving Gentech USA LLC
- 2025-08-29: 98894970 — EXTENSION OF TIME GRANTED involving Bausch Health Ireland Limited
- 2025-08-29: 98894970 — FINAL 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Bausch Health Ireland Limited
- 2025-06-05: 98894970 — EXTENSION OF TIME GRANTED involving Bausch Health Ireland Limited
- 2025-06-05: 98894970 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Bausch Health Ireland Limited
- 2025-01-16: 98535422 — EXTENSION OF TIME GRANTED involving Biocon Biologics Limited
- 2025-01-16: 98535422 — ADD'L 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Biocon Biologics Limited
- 2024-12-13: 98535422 — EXTENSION OF TIME GRANTED involving Biocon Biologics Limited
- 2024-12-13: 98535422 — FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE involving Biocon Biologics Limited
- 2023-08-19: 79367968 — EXTENSION OF TIME GRANTED involving NOVARTIS AG
- 2023-08-18: 79367968 — ADD'L 60-DAY REQUEST TO EXT TIME TO OPPOSE involving NOVARTIS AG
- 2023-08-17: 97431092 — EXTENSION OF TIME GRANTED involving Empire Pharmaceutical Inc.
- 2023-08-17: 97431092 — FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE involving Empire Pharmaceutical Inc.